Bayer gets FDA warning over quality control By Bert-Friedrich Fröndhoff and Siegfried Hofmann Siegfried Hofmann
Bayern had a quality problem. Please write-up a short description of the situation addressing:
1. Description of the quality problem and how it came about.
2. What has it done to the entity's market value and branding image?
3. Is there a recovery plan?
4. How could it have been avoided?